GHOSH ANIRVAN (Chief Executive Officer) sold 0.8% of their position (604.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $924.12 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2024ACC: 0000950170-24-091965
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-604.00
Net shares
Net seller
$924.12
Total sold
1
Open market trades
0B · 1S
1
Total transactions
604.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−604.00
Price / share
$1.53
Trade value
$924.12
% of position
0.8%
8/2/2024
76.93K→76.33K
Total
Net shares
−604.00
Net value
-$924.12
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 8/2/2024 | S · Sale | −604.00 | $1.53 | $924.12 | 0.8% | 76.93K | 76.33K |
| Total | −604.00 | -$924.12 | ||||||
Derivative Transactions0
No derivative transactions reported